BAFF
Showing 1 - 25 of 109
Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)
Recruiting
- Multiple Myeloma
- APRIL-BAFF-Bicephali CAR-T cells
-
Xuzhou, Jiangsu, ChinaKailin Xu
Nov 14, 2023
Multiple Myeloma, Refractory, Multiple Myeloma in Relapse Trial in Cleveland (Autologous CAR-T cell therapy expressing the
Not yet recruiting
- Multiple Myeloma, Refractory
- Multiple Myeloma in Relapse
- Autologous CAR-T cell therapy expressing the BAFF-ligand.
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center
Jan 11, 2023
Lymphoma, Non-Hodgkin Lymphoma, B-Cell Trial (BAFF CAR-T)
Not yet recruiting
- Lymphoma, Non-Hodgkin Lymphoma, B-Cell
- BAFF CAR-T
- (no location specified)
Aug 16, 2022
Systemic Lupus Erythematosus and Rheumatoid Arthritis
Recruiting
- Systemic Lupus Erythematosus
- +2 more
- Belimumab in SLE patients / Rituximab in RA patients
-
Monserrato, Cagliari, ItalyMatteo Piga
Dec 13, 2022
Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))
Withdrawn
- Primary Sjogren's Syndrome
- tibulizumab (LY3090106)
-
Palo Alto, CaliforniaStanford University
Jan 12, 2022
Kidney Transplantation, Kidney Transplant Rejection Trial in Guangzhou
Not yet recruiting
- Kidney Transplantation
- Kidney Transplant Rejection
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital, Sun Yat-sen University
Mar 19, 2023
Glycation and Inflammation in Acute Ischemic Heart Disease
Recruiting
- Myocardial Infarction
- +4 more
- BAFF and MGO
-
Milano, ItalyIstituto Clinico Città Studi
Jul 7, 2022
Immune Thrombocytopenia (ITP), Systemic Lupus Erythematosus (SLE) Trial in Créteil, Paris (Bliss-Believe)
Unknown status
- Immune Thrombocytopenia (ITP)
- Systemic Lupus Erythematosus (SLE)
- Bliss-Believe
-
Créteil, France
- +1 more
May 21, 2021
BAFF Levels and Lupus Nephritis (LN)
Not yet recruiting
- Lupus Nephritis
- BAFF serum levels
- (no location specified)
Apr 30, 2020
IBS - Irritable Bowel Syndrome, Inflammation Trial in Milano (Rotation Diet)
Completed
- IBS - Irritable Bowel Syndrome
- Inflammation
- Rotation Diet
-
Milano, ItalyGEK srl
Apr 15, 2020
Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,
Recruiting
- Rheumatoid Arthritis
- +8 more
- Moderna mRNA-1273
- +5 more
-
Los Angeles, California
- +24 more
Aug 17, 2022
Type I IFN Level and Disease Activity in SLE Patients
Not yet recruiting
- Elevated Level of IFN Type I in SLE Patients
- study of IFNGS expression biomarkers
- (no location specified)
Jun 30, 2022
Antibody-mediated Rejection, NMO Spectrum Disorder, TTP Trial in Iowa City
Recruiting
- Antibody-mediated Rejection
- +3 more
-
Iowa City, IowaDeGowin blood Center
Oct 31, 2022
BAFF and APRIL and RESPONSE TO BELIMUMAB in SLE
Unknown status
- Systemic Lupus Erythematosus
- BAFF Polymorphism
- (no location specified)
Apr 15, 2019
Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease
Recruiting
- Fabry Disease
-
Rockville, Maryland
- +1 more
Sep 29, 2023
Primary Immune Thrombocytopenia (ITP) Trial (Combination of Rituximab with subcutaneous belimumab, Combination of Rituximab with
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- Combination of Rituximab with subcutaneous belimumab
- Combination of Rituximab with subcutaneous placebo
- (no location specified)
Apr 15, 2022
ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)
Recruiting
- ANCA-associated Vasculitis
- Maintenance Therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Lupus Erythematosus, Systemic Trial in Netherlands (Belimumab Injection)
Recruiting
- Lupus Erythematosus, Systemic
- Belimumab Injection
-
Groningen, Netherlands
- +3 more
Mar 14, 2022
ANCA Associated Vasculitis Trial in Beijing (Telitacicept, Placebo of Telitacicept)
Recruiting
- ANCA Associated Vasculitis
- Telitacicept
- Placebo of Telitacicept
-
Beijing, ChinaPeking Union Medical College Hospital
Jul 19, 2023
Periodontitis Trial in Istanbul (Initial periodontal treatment)
Completed
- Periodontitis
- Initial periodontal treatment
-
Istanbul, TurkeyBiruni University
Aug 12, 2022
Autoimmune Diseases Trial in Shenzhen, Guilin (4SCAR T cells)
Recruiting
- Autoimmune Diseases
- 4SCAR T cells
-
Shenzhen, Guangdong, China
- +1 more
Jul 17, 2022
Kidney; Complications, Allograft, Transplantation Infection Trial in Loma Linda (Immunosuppressive Agents)
Active, not recruiting
- Kidney; Complications, Allograft
- Transplantation Infection
- Immunosuppressive Agents
-
Loma Linda, CaliforniaLoma Linda University Medical Center, Transplantation Institute
Apr 28, 2022
Donor Specific B Cells and Antibody Mediated Rejection
Terminated
- Sensitized Kidney Transplant Recipients
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Dec 13, 2021
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (VAY736, VAY736 Placebo, CFZ533)
Active, not recruiting
- Systemic Lupus Erythematosus (SLE)
- VAY736
- +3 more
-
Ciudad Autonoma de Bs As, Buenos Aires, Argentina
- +31 more
Sep 19, 2022
Towards a Functional Cure for HBV - The COMMIT Cohort Study
Active, not recruiting
- Hiv
- HBV Coinfection
-
Chennai, India
- +2 more
May 30, 2022